{
  "contract_version": "supplier-contract-v0.1",
  "project": "col-901831",
  "supplier_group_id": "FLIER",
  "generated_at": "2026-04-11T03:49:09.932Z",
  "model": "gpt-4.1-mini",
  "provider_stack": [
    "openai"
  ],
  "narratives": {
    "positioning_summary": "FLIER是一家来自香港的注射器供应商，2010-2014年市场份额为1.02%，处于退场阶段。",
    "buyer_strategy": "其海外买家高度集中，Top1买家LABORATORIO FRANCO COLOMBIANO LAFRANCOL S.A.S.占97.3%，替代难度较大但锁定该买家即可快速切入。",
    "pricing_read": "均价高出市场122.4%，主战场在$0.1726–$0.2520价格带，占80.5%，建议从$0.0260–$0.0380低价段切入抢占市场。",
    "trend_read": "末年销售仅为峰值31%，买家净减1家，明显退场趋势。",
    "competitive_angles": {
      "strengths": [
        "Top1买家LABORATORIO FRANCO COLOMBIANO LAFRANCOL S.A.S.占97.3%",
        "CAGR达19.7%，有一定增长潜力",
        "主要出货港口Cali占比99%"
      ],
      "weaknesses": [
        "均价高出市场122.4%，价格竞争力弱",
        "买家数仅2个，客户依赖度极高",
        "买家趋势为净流失，2013年买家流失明显"
      ],
      "how_to_attack": "优先抢占LABORATORIO FRANCO COLOMBIANO LAFRANCOL S.A.S.；以$0.0260–$0.0380低价段切入，突出性价比优势；采用混合付款方式，主攻Cali港口，提供更灵活交付方案。"
    },
    "buyer_opportunities": [
      {
        "buyer": "LABORATORIO FRANCO COLOMBIANO LAFRANCOL S.A.S.",
        "angle": "Top依赖且价格高位",
        "action": "本周联系该买家，报价$0.0260–$0.0380区间，强调价格优势和灵活付款条件"
      },
      {
        "buyer": "LABORATORIO FRANCO COLOMBIANO LAFRANCOL S.A.S.",
        "angle": "流失买家",
        "action": "针对2013年流失批次，提供更低价和更优质服务，争取重新合作"
      },
      {
        "buyer": "LABORATORIO FRANCO COLOMBIANO LAFRANCOL S.A.S.",
        "angle": "港口集中",
        "action": "利用Cali港口99%出货优势，提供快速交付和本地化支持"
      }
    ]
  }
}